About: Tamoxifen in combination with cytotoxic chemotherapy in advanced epithelial ovarian cancer. A prospective randomized trial

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Tamoxifen in combination with cytotoxic chemotherapy in advanced epithelial ovarian cancer. A prospective randomized trial Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 March 1989

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в березні 1989 (uk) article scientifique publié en 1989 (fr) im März 1989 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en marzu de 1989 (ast) scientific article published on 01 March 1989 (en)
publication date	wds:Q69947798-A1CBA297-18D2-4CA3-9BCC-D66264057102
publication date	1989-03-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q69947798-A4D9831C-F4B3-4863-8494-028C67399776
language of work or name	English
author name string	wds:Q69947798-3039FA7C-90AF-4E39-9115-F9B7824289F4 wds:Q69947798-4B4CB1BB-C30D-401C-BFED-4B3B6C93F490 wds:Q69947798-76128CA2-2A27-491C-B730-D5D6EBAB7505 wds:Q69947798-763EF0EB-4C67-46CA-96A3-C9BD1803BCFB wds:Q69947798-7D303D27-22D9-4E8D-8415-351B20FD434F wds:Q69947798-7F77A801-54E6-4CDD-B6E1-69598B96F99D wds:Q69947798-9909C43B-B54B-43E6-829C-FC0D9ACC1391 wds:Q69947798-B228599F-63C0-4B9B-9E41-756B536EA93C
author name string	P E Schwartz E I Kohorn J T Chambers S K Chambers F Naftolin H Weitzman I M Voynick N MacLusky
rdfs:label	Tamoxifen in combination with cytotoxic chemotherapy in advanced epithelial ovarian cancer. A prospective randomized trial (en) Tamoxifen in combination with cytotoxic chemotherapy in advanced epithelial ovarian cancer. A prospective randomized trial (nl)
skos:prefLabel	Tamoxifen in combination with cytotoxic chemotherapy in advanced epithelial ovarian cancer. A prospective randomized trial (en) Tamoxifen in combination with cytotoxic chemotherapy in advanced epithelial ovarian cancer. A prospective randomized trial (nl)
name	Tamoxifen in combination with cytotoxic chemotherapy in advanced epithelial ovarian cancer. A prospective randomized trial (en) Tamoxifen in combination with cytotoxic chemotherapy in advanced epithelial ovarian cancer. A prospective randomized trial (nl)
title	wds:Q69947798-11E35CF4-B2F2-4293-8025-7ECF04781A49
title	Tamoxifen in combination with cytotoxic chemotherapy in advanced epithelial ovarian cancer. A prospective randomized trial (en)
page(s)	wds:Q69947798-CBBFCF8B-B477-43D0-94DC-E6C216CB2120
page(s)	1074-1078
instance of	wds:Q69947798-21B60C80-9D97-4D13-90B3-E969958082CE
instance of	scholarly article
main subject	wds:Q69947798-20D1DFA9-9F82-4F55-8D05-0303E5E6A1EC wds:Q69947798-7C55A447-4B24-432D-BA82-15680BC46A2A
main subject	chemotherapy wd:Q412178
PubMed ID	wds:Q69947798-13181829-189A-4B06-8AA7-AF9697C5C62E
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/2917311
PubMed ID	2917311
published in	wds:Q69947798-15A81C61-7D90-44A1-8CCC-CF2CC6E7F897
published in	Cancer
issue	wds:Q69947798-7C67BBA5-9837-4DA2-8BCE-DF6629368D73
volume	wds:Q69947798-627F6591-1483-4C77-8AEE-349CCD024B8E
issue	6
volume	63
DOI	wds:Q69947798-B8CF49EA-A347-4CC6-93A5-2A89CD06AEC5
DOI	http://dx.doi.org/10.1002/1097-0142(19890315)63:6%3C1074::AID-CNCR2820630606%3E3.0.CO;2-0
DOI	10.1002/1097-0142(19890315)63:6<1074::AID-CNCR2820630606>3.0.CO;2-0
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q69947798
is cites work of	Estrogen signaling crosstalk: Implications for endocrine resistance in ovarian cancer Ovarian and breast cancer spheres are similar in transcriptomic features and sensitive to fenretinide Pharmaceutical management of ovarian cancer : current status Epidermal growth factor, oestrogen and progesterone receptor expression in primary ovarian cancer: correlation with clinical outcome and response to chemotherapy. Molecular clustering based on ERα and EIG121 predicts survival in high-grade serous carcinoma of the ovary/peritoneum Prognostic value of hormonal receptors, p53, ki67 and HER2/neu expression in epithelial ovarian carcinoma Luteinizing hormone-releasing hormone agonist triptorelin in combination with cytotoxic chemotherapy in patients with advanced ovarian carcinoma. A prospective double blind randomized trial. Decapeptyl Ovarian Cancer Study Group Role of CT and MR imaging in predicting optimal cytoreduction of newly diagnosed primary epithelial ovarian cancer. Tamoxifen for relapse of ovarian cancer MAPK Activation Predicts Poor Outcome and the MEK Inhibitor, Selumetinib, Reverses Antiestrogen Resistance in ER-Positive High-Grade Serous Ovarian Cancer A brief review of the management of platinum-resistant-platinum-refractory ovarian cancer Tamoxifen synergizes the antiproliferative effect of cisplatin in human ovarian cancer cells: enhancement of DNA platination as a possible mechanism Clinical trials in patients with epithelial ovarian cancer: past, present and future Clinical benefit and risk of death with endocrine therapy in ovarian cancer: A comprehensive review and meta-analysis Antiestrogen therapy in recurrent ovarian cancer resulting in 28 months of stable disease: a case report and review of the literature The role of hormonal factors and endocrine therapy in ovarian cancer New insights on the role of hormonal therapy in ovarian cancer Activation of estrogen receptor α by estradiol and cisplatin induces platinum-resistance in ovarian cancer cells. The roles of pathology in targeted therapy of women with gynecologic cancers. Dose intensity analysis in advanced ovarian cancer patients The oestrogen receptor (ER) in vulva, vagina and ovary Hormonal strategies in gynecologic cancer: Bridging biology and therapy
is cites work of	wds:Q34682062-571E91A9-98AE-46CC-84A7-BDF0A2356012 wds:Q24236581-69AA3921-FB6C-4347-9C7B-3436EF4C5A1F wds:Q35138497-67AC31D0-B071-4CFD-AABD-95DD028528B3 wds:Q39433419-153DBF83-BEE2-498B-B6B7-F2B312E2ECEF wds:Q36936727-98E00854-23B4-463E-AAA6-158F4A8CCCE5 wds:Q35975958-D7C73ECA-2DF6-47DE-AE40-2DCE780025A0 wds:Q40925323-A351FBE7-30F2-4619-8B48-B1B7FD347686 wds:Q73135110-48CC576A-FD23-4B3C-9A9E-D210D62867F5 wds:Q36001247-47DCF886-0C1F-4EA6-B72B-E4A270D7B010 wds:Q60768392-12BCF778-F19A-40C9-B933-FE5CA079F5CE wds:Q89203991-1A56AF7B-45E1-43E2-A864-394B797D7D76 wds:Q36586093-937C2E5E-5BE0-4694-9817-F96FCC40184C wds:Q36081524-599DDDD3-EE8C-4A12-A1A9-6EE6876E2ADF wds:Q37275730-3126A406-423C-4DB6-81BA-A0629688C978 wds:Q39263789-A218F653-3663-4130-9C68-4B649CC02DF3 wds:Q46536506-231E2883-2B3B-4AA4-889B-AEECECE61CEF wds:Q53597473-2B7B247F-187E-47AE-A43D-63D92133D130 wds:Q71611166-CD14A14B-6AB9-4D1C-AC25-E6AA30DFF070 wds:Q34022694-74889262-7495-422B-BE53-B1392D8CAF53 wds:Q37139726-A583CE4D-F66E-4854-95EF-6018CC7F853B wds:Q46425884-217576E6-8456-4C88-AC0F-677F999C4B00 wds:Q49645276-138DD1F4-1E8A-4311-BC42-5EAF3BDDCC67

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 183 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software